Search results
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 6 days agoCombination vaccines have been successfully used for several decades in Australia and around the...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 3 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 7 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 2 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 15 hours agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant...
Centers for Disease Control and Prevention· 3 days agoVaccine Effectiveness among Household Contacts
Gateway - Quartz
Quartz· 3 days agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 7 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 7 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target ...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 5 days agoThis underperformance of Pfizer stock can be attributed to declining revenues after the surge in Covid-19 vaccine demand during the pandemic ...